secwatch.observer — SEC 8-K summary
======================================

Issuer:     International Stem Cell CORP (ISCO)
CIK:        0001355790
Form:       8-K
Filed at:   2022-09-16T23:59:59+00:00
Accession:  0001683168-22-006449
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO extends $2.9M loan maturity to March 2023 at 4.5% interest
--------------------------------------------------------------

- On Sep 15, 2022, International Stem Cell Corp. extended maturity of $2.9M loan from CEO Andrey Semechkin to Mar 15, 2023.
- The loan originally issued Mar 1, 2022 was due Sep 15, 2022; replaced with new unsecured, non-convertible note.
- Interest rate remains 4.5% per annum; company may prepay without penalty.
- Dr. Semechkin is Co-Chairman and CEO; transaction is a related-party extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1355790/000168316822006449/0001683168-22-006449-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1355790/000168316822006449/isco_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-006449

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer